The collaboration was formed to discover novel small molecules for an undisclosed target using Vernalis’ fragment and structure-based drug discovery technology. Vernalis said the final payment is in
Oral retinoid compound tamibarotene, which was designed to be superior to all trans-retinoic acid (ATRA) by binding to the molecular target more selectively, proved to be 10 times
The firm is planning to invest the fund in its Phase I clinical development of SB 9200, a novel, orally available treatment for Hepatitis C virus (HCV) infection
The firm is planning to use the fund to commercialize its portfolio of dysphagia treatment products and to add new products and services. Venture Management president Terry Kelly
The firm’s new tunnels are equipped with Intense Pulsed UV flash lamps, which contain UV transparent conveyer and capable of sterilizing the entire product surfaces with the reduction
Under the agreement, RxMedic will immediately become a distributor of Rx Systems’ Eyecon Countertop Counter, along with their existing line of advanced pharmacy automation systems. The Eyecon is
Under $130,000 grant, TriLink plans to investigate methods to reduce formation of adapter dimers during RNA sample preparation, which will remove the need for gel purification prior to
The platform was built by integrating Roche’s REM e System with Hamilton’s Microlab NIMBUS NGS workstation, which uses advanced robotic pipetting technologies to speed the liquid handling process.
Kala said Crown Venture Fund is the new and lead investor who joined its existing investors including Lux Capital Management, Polaris Venture Partners and Third Rock Ventures. The
Under the alliance, M*Modal will serve its M*Modal Catalyst analytics platform and the Claro Group will provide its consulting services to the physicians and healthcare professionals, which can
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.